Impairment of Nuclear Development Due to Lack of B12 or Folate

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 184 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Macrocytic Anemias. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Macrocytic Anemias (online CE course)
Impairment of Nuclear Development Due to Lack of B12 or Folate

The cause of impaired nuclear development in megaloblastic anemia is either an impairment or lack of vitamin B12 or folate utilization. Both vitamins are essential for DNA synthesis and work within the same cycle. Thus, if either is deficient, the cycle will not continue and DNA synthesis will be impaired. The development of the nucleus will lag behind cytoplasmic development, a situation known as asynchronous maturation. Additionally, the abnormal precursor cells may die through apoptosis leading to anemia.
Please see the B12/folate metabolic cycle to the right. To explain: vitamin B12 is necessary to drive the folate cycle, which is important in converting uridylates to thymidylates, which are necessary for the production of the nucleic acid thymidine, which is necessary for DNA synthesis.
One important fact to keep in mind: Not all patients who have B12 or folate deficiencies will necessarily exhibit macrocytosis. It is possible that the patient could also have a concomitant iron deficiency. Iron-deficient erythropoiesis, which typically produces microcytic cells, can mask macrocytosis. More about this under laboratory diagnosis and testing.
2. Creative Commons. "Plasma and Red Cell Reference Intervals of 5-Methyltetrahydrofolate of Healthy Adults in Whom Biochemical Functional Deficiencies of Folate and Vitamin B12 Had Been Excluded." PubMed. 15 Jan 2014, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914575/

B12 and folate metabolism. (2)
DHF=dihydrofolate; THF=tetrahydrofolate